Identify gaps in the literature and ongoing research directions Key gaps include a lack of large, controlled clinical trials, unclear optimal dosing and delivery for reproductive targets, limited long-term safety data for systemic use, and few mechanistic human studies linking molecular changes to fertility outcomes
Nearly all about Key Fertility Peptides
[(accessed on 19 June 2020)];Control Clin
Moreover, a substantial methodological heterogeneity, including inconsistent protocols, lack of blinding, and unclear randomisation, limits the robustness of the conclusions
doi: 10.3390/ijms18061280
Reduces Visceral Belly Fat Tesamorelin is FDA-approved for treating excess abdominal fat in HIV patients with lipodystrophy, but its fat-burning effects extend beyond that population